Controversies and Trust in COVID Treatments

This chapter examines the contentious discussions around ivermectin and hydroxychloroquine, exploring how political narratives affect public perceptions of these treatments. It critiques the pharmaceutical industry's motivations, the censorship of contradicting opinions, and the implications of rapid vaccine deployment during the pandemic. The conversation also highlights concerns about long-term vaccine safety and the unequal treatment of local businesses during health crises.